Birbeck granules are unusual rod shaped structures specific to epidermal Langerhans cells, whose origin and function remain undetermined. We investigated the intracellular location and fate of Langerin, a protein implicated in Birbeck granule biogenesis, in human epidermal 
INTRODUCTION
Langerhans cells, the representatives of the dendritic cell lineage in the epidermis and mucosal tissues, capture antigen in the skin before migrating to the T cell-dependent areas of draining lymph nodes. During this migration, they undergo a maturation process which allows them to present antigens to naive T cells (Kripke et al., 1990; Moll et al., 1993) . Notably,
Langerhans cells are the only epidermal cells to constitutively express Major
Histocompatibility Complex (MHC) class II molecules (Rowden et al., 1977; Klareskog et al., 1977) , CD1a molecules (Fithian et al., 1981) and Langerin (Valladeau et al., 2000) at their cell surface. In addition, Langerhans cells differ ultra-structurally from other dendritic cells through the presence of Birbeck granules, distinctive rod-shaped structures of variable length with a central, periodically striated lamella (Birbeck et al., 1961) .
Despite the use of "dynamic" electron microscope studies (reviewed in Schuler et al., 1991) , Birbeck granules remain enigmatic. Specifically, conflicting theories exist regarding their derivation and function. The "secretion/exocytosis theory" suggests an intracellular origin from either the Golgi apparatus or endosomes. In this model, Birbeck granules would take up intracellular ligands and transport them either to the cell surface or an unknown intracellular destination (Zelickson 1966; Wolff 1967; Hanau et al., 1987) . Alternatively, the "endocytosis theory" posits that Birbeck granules originate from the cell membrane, during receptor-mediated endocytosis, as a prolongation of coated pits which pinch off to form intracellular Birbeck granules. Once formed, these structures would potentially deliver ligands to endosomal, pre-lysosomal and lysosomal compartments (Ishii et al., 1985; Takigawa et al., 1985; Bartosik, 1992) .
The recent characterisation of Langerin has provided some insight into the biogenesis of Birbeck granules. Langerin is a transmembrane type II Ca 2+ -dependent lectin with a single carbohydrate recognition domain displaying mannose-binding specificity and an intracellular 4 proline-rich motif (Valladeau et al., 2000) . The presence of Langerin is sufficient to promote the appearance of structures similar to Birbeck granules in murine fibroblastic cells (Valladeau et al., 2000) , suggesting that it may equally be involved in their formation in human Langerhans cells.
In an attempt to resolve some of the persistent issues surrounding the origin and function of these unusual cell specific structures, we undertook a study of Birbeck granules in human epidermal Langerhans cells. Given the implication of Langerin in their biogenesis, we specifically studied the relationship between Langerin and Birbeck granules in these cells.
Our results demonstrate that in freshly isolated Langerhans cells, recycling Langerin is dynamically retained in the endosomal recycling compartment and that Birbeck granules form where Langerin accumulates. They also demonstrate that Birbeck granules constitute a subdomain of the endosomal recycling compartment.
MATERIALS AND METHODS

Antibodies and Reagents.
Mouse mAbs were as follows: anti-lag (IgG1, recognising an intracellular epitope of Langerin, kindly provided by Dr Sadao Imamura, Kyoto University, Sakyo-ku, Kyoto, Japan) (Kashihara et al., 1986; Valladeau et al., 2000) , DCGM4 (IgG1, recognising an extracellular epitope of Langerin, Immunotech, Marseille, France) (Valladeau et al., 1999) , L243 (IgG2a, anti-DRαβ dimers, Becton Dickinson Immunocytochemistry Systems, San Jose, CA), FITC-conjugated H1149 (IgG1, anti-CD1a, Pharmingen, San Diego, CA), H5C6 (IgG1, anti-CD63, kindly provided by Dr François Lanza, EFS-Alsace, Strasbourg), TRITC-conjugated Phalloidin (Sigma Diagnostics, St Louis, MO) and H4B4
(IgG1, anti-Lamp-2 (CD107b), Pharmingen). Rabbit anti-EEA1 antiserum (Simonsen et al., 1998 ) was a generous gift of Dr Harald Steinmark, (EMBL, Heidelberg, Germany). CTR433, 5 a mouse mAb recognising a cis/medial Golgi antigen (Jasmin et al., 1989) was provided by Dr. Michel Bornens (Institut Curie, Paris). A polyclonal rabbit anti-Rab11 Ab was raised against full length recombinant Rab11 expressed in Escherichia coli and affinity purified essentially as described previously (Martinez et al., 1994 for indirect immunofluorescence staining procedures in confocal microscopy. Goldconjugated Fab fragments of the anti-CD1a mAb BL6 (Immunotech) (anti-CD1a-Au) for electron microscopy were obtained from Aurion (Wageningen, The Netherlands). The antiLangerin mAb DCGM4 was labelled with 10-nm gold particles (Goldsols EM-10 nm, Aurion) (DCGM4-Au) as previously reported (Hanau et al., 1987 stored at -20°C in ethanol as a 5 mg/ml and a 1 mg/ml stock solution, respectively.
Preparation and Culture of Epidermal Cells.
Cell suspensions were prepared from normal human skin taken from patients undergoing abdominal plastic surgery, as previously described (Hanau et al., 1987) . These suspensions initially contained 0.5 to 2 % freshly isolated (Fi) Langerhans cells (LCs) and were enriched in LCs by gradient centrifugation on Lymphoprep (Flobio SA, Courbevoie, France) giving an LC yield typically 30-50% of the final cell population.
Cultures of epidermal cell suspensions enriched in LCs were established in RPMI 1640 medium containing Glutamax-I, 10% heat inactivated FCS, 1% sodium pyruvate, 50 U/ml penicillin and streptomycin (all from Life Technologies, Paisley, UK), 50 ng/ml recombinant human GM-CSF and 30 ng/ml recombinant human TNF-α (hereafter referred to as complete medium).
Flow Cytometry. Epidermal cells enriched in Fi LCs were washed once in RPMI 1640
supplemented with 10% FCS and resuspended in the same medium. The cells were incubated for 60 min at 37°C in the presence of either BFA (10 µg/ml), latrunculin A (12.5 µg/ml), cytochalasin D (10 µg/ml), or BFA and cytochalasin D (10 µg/ml each) and then cooled to 4°C. LCs were labelled by incubation with the anti-Langerin mAb DCGM4 (30 min at 4°C) and then, after two washes at 4°C, with the FITC-conjugated F(ab') 2 fraction of a sheep antimouse Ig Ab (30 min at 4°C). After washing, the cells were fixed and analysed with a FACScan cytometer (Becton Dickinson). IgG1 isotype controls were stained and examined simultaneously. The same procedure was used to analyse LCs cultured for 12, 24 or 48 hours, in some experiments after pre-treatment of the cells with either cytochalasin D (10 µg/ml), or BFA and cytochalasin D (10 µg/ml each).
Immunofluorescence Staining and Confocal Microscopy.
Immunofluorescence microscopy of fixed permeabilised LCs was carried out as previously described (Saudrais et al., 7 1998 followed by donkey anti-mouse TRITC and finally an FITC-conjugated anti-CD1a mAb to visualize in LCs the effects of BFA on Golgi distribution. Confocal laser scanning microscopy and immunofluorescence quantification were performed as previously described (Salamero et al., 1996) In a final series of experiments, Fi epidermal cells and LCs cultured for 48 hours were incubated at 37°C for 30 min with BFA (10 µg/ml) and then for 60 min in the presence of BFA (5 µg/ml) and HRP (10 mg/ml). The cells were subsequently processed according to Tooze and Hollinshead (1991) and Griffiths et al. (1989) . After washing in PBS and fixation with 0.5% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.3, for 30 min at room temperature, the cells were washed in cacodylate buffer and incubated with DAB for 1 min.
The HRP-DAB reaction was initiated by adding H 2 O 2 to a final concentration of 0.01%. After 30 min in the dark, the reaction was terminated by washing several times in cacodylate buffer and the cells were postfixed in 1% osmium tetroxide, washed again in cacodylate buffer and further processed as for conventional electron microscopy. Thick and ultrathin sections were examined under a Philips CM 120 BioTwin electron microscope (120 kV), in most cases without post-staining to allow better differentiation of the HRP-DAB reaction product.
RESULTS
Langerin is Associated with the Rab11 + /CD1a + Recycling Compartment
As an initial step, we characterised the distribution of Langerin in freshly isolated ( Rather, some co-localisation between the internal pool of Langerin, as revealed by the anti-lag mAb, and the LC marker CD1a was evident in the pericentriolar area ( Figure 1D ). In another study carried out in the same cell type, we demonstrated that intracellular CD1a also colocalises with Rab11 (Salamero et al., 2001) , a small GTPase which specifically associates with the membrane of the endosomal recycling compartment (ERC) (Ullrich et al., 1996; Ren et al., 1998) . Steady-state internal Langerin colocalised strongly with Rab11 in the ERC ( Figure 1E ) but poorly with EEA1, a marker of the early/sorting endosomes ( Figure 1F ) (Simonsen et al., 1998; McBride et al., 1999; Christoforidis et al.,1999) . The steady-state localisation of Langerin was clearly different from that of CD1a, the latter being more equally distributed between the cell surface and internal membranes, however, this could be related to the dual role of the ERC as a sorting compartment for internalised proteins (Ghosh et al., 1998; Mallet and Maxfield, 1999; Wilcke et al., 2000) , and as a storage reservoir for the regulated delivery of proteins to the plasma membrane (Johnson et al., 2001) . Hence, we next investigated whether Langerin, which is already known to endocytose in LCs (Valladeau et al., 1999; Valladeau et al., 2000) , cycles through the early endosomal pathway in a similar fashion to CD1a molecules.
Cell Surface Langerin Internalises through Classical Endocytic Structures before
Reaching Birbeck Granules
In order to define the different endocytic structures through which cell surface Langerin traffics, cells were incubated in the presence of the anti-Langerin mAb DCGM4 over a range of temperatures. While at 4°C, DCGM4 labelled only the LC surface ( Figure 2A ), at 19.5°C it reached peripheral vesicular compartments distinct from the Rab11 + ( Figure 2B ) and CD1a + ( Figure 2C ) ERC. The majority of these structures were identified as EEA1 + early/sorting endosomes ( Figure 2D ). In contrast, incubation at 37°C allowed DCGM4 to reach the Rab11 + ( Figure 2F ) and CD1a + ( Figure 2E ) ERC. No transport to late endosomal structures such as Lamp-2 + or Lamp-3/CD63 + positive compartments was detected at any time (our unpublished results). These results suggested that in Fi LCs, Langerin traffics between the plasma membrane, the early/sorting endosomes and the ERC, as might be expected for a recycling molecule. Using electron microscopy, we attempted to detail more precisely the organelles involved in this pathway and, in particular, the relationship between internalised Langerin and BGs. Fi LCs were incubated with DCGM4-Au for 60 min at 19.5°C and either immediately fixed at 19.5°C or warmed to 37°C for 10, 20 or 30 min before fixation. In LCs fixed at 19.5°C, temperature conditions known to inhibit cargo protein transfer from the early/sorting endosomes to the ERC (Ren et al., 1998; Wilcke et al., 2000) , few gold particles were visible on the cell surface, most being concentrated in coated pits ( Figure 3A) . There was also labelling of coated vesicles ( Figure 3A ), tubular structures ( Figure 3A , B) and electron lucent compartments close to the cell surface, suggestive of early endosomes ( Figure 3C , D). As expected, progression of Langerin appeared to be blocked in these early endosomal like structures, as illustrated by the accumulation of gold-labelled anti-Langerin mAb in these compartments ( Figure 3D ). Notably, no BGs were observed in continuity with the cell surface, nor was internalised DCGM4-Au detected in BGs ( Figure 3D ). In contrast, when LCs were further incubated at 37°C prior to fixation, gold labelling became apparent in the pericentriolar region, consistent with the results obtained by immunofluorescence. While labelling persisted in vesicular and tubular structures ( Figure 3H ), the central linear striated density of pericentriolar BGs now contained gold particles ( Figure 3E-H) . Interestingly, coated structures replete with DCGM4-Au were also present in the cell centre ( Figure 6G) and, in certain planes, appeared to be in continuity with tubular structures ( Figure 6G ). Once again, no BGs were detected in continuity with the cell membrane. These observations illustrate that Langerin is internalised in Fi LCs by classical clathrin coated receptor-mediated endocytosis. They also show that pericentriolar BGs and recycling compartments are accessible to anti-Langerin mAb, like CD1a antibodies, in a temperature dependent manner (Salamero et al., 2001) . Such findings indicate that Langerin behaves as a recycling molecule in Fi LCs and suggest that BGs could be part of or connected to the ERC.
Inhibition of Endocytosis Induces a Redistribution of Intracellular Langerin and the
Appearance of "Birbeck Granule-like Structures" at the Cell Surface
If Langerin undergoes a recycling process, inhibition of endocytosis under conditions where recycling to the plasma membrane is not affected should allow the internal pool to redistribute to the plasma membrane. Cytochalasin D and latrunculin A, known respectively to depolymerise and sequester F-actin filaments, have been shown to block the initial steps of endocytosis without affecting the recycling pathway in various cell types, including Fi LCs (Durrbach et al., 1996; Lamaze et al., 1997; Salamero et al., 2001) . Having confirmed by immunofluorescence their expected effects on filamentous actin in this cell type (our unpublished resuslts), we found that latrunculin A ( Figure 4B ) and cytochalasin D (our 13 unpublished resuslts) were equally efficient in blocking the internalisation of the mAb DCGM4 bound to Langerin at the surface of Fi LCs (compare Figure 4B to Figure 4A ).
Inhibition of endocytosis by either of these drugs resulted in approximately a 10-fold increase in cell surface Langerin expression, as measured by FACS analysis ( Figure 4E ). This was accompanied by a redistribution of the internal Langerin pool towards the cell surface, as seen on confocal microscopy images (compare Figure 4C and 4D). Since this dramatic increase in cell surface expression could conceivably have been augmented by the export of newly synthesised Langerin molecules to the plasma membrane, we next examined the effect of BFA, a drug known to block the early biosynthetic/secretory pathway , on Langerin expression. We first confirmed the effect of BFA on the redistribution of the (Hanau et al., 1988) . Whereas in non treated LCs, approximately 98% of BGs are not appended to the cell surface (Table I) In cells fixed immediately, the cell surface was weakly labelled, with most gold particles concentrated in coated pits ( Figure 6D ). Labelling accumulated in the pericentriolar area ( Figure 6G ) where it was found in vesicular and tubular structures, in the central linear striated density of BGs and in coated organelles which were sometimes in continuity with tubular structures ( Figure 6G ). Chase in the presence of cytochalasin D resulted in a relocalisation of this labelling to the cell surface ( Figure 6E ), with almost none remaining in the pericentriolar area ( Figure 6H ). Although pericentriolar BGs remained, none contained gold particles. In contrast, many of the numerous BG-like structures and coated pits visible at the cell surface were labelled ( Figure 6E ). These structures were frequently coated, whether along all their length or simply at their distal end, the gold particles lying along the central linear striated density and/or in the coated distal end. These findings show that anti-Langerin mAbs travel from the periphery of the cell to the pericentriolar area, where they label Rab11 + compartments and BGs, before subsequently returning to the cell surface. This not only confirms the recycling of Langerin at the ultra-structural level, but also demonstrates that the pericentriolar BGs belong to this pathway.
Brefeldin A Partially Inhibits Recycling of Internalised Langerin
Ultra-structural studies of the internalisation of the anti-Langerin mAb DCGM4 revealed ( Figure 6G ) the existence of numerous coated structures filled with gold particles in the pericentriolar area. In addition, confocal microscopy studies showed that internalised DCGM4 accumulated in the Rab11 + ERC ( Figure 2E , F). These two findings suggested that the coated structures might represent transport intermediates involved in Langerin recycling. Small G proteins of the Arf (ADP-ribosylation factor) family recruit and assemble protein complexes, leading to the formation of cellular coats. This requires their interaction with Arf exchange factors which catalyse the exchange of GDP for GTP, a process which can be inhibited by BFA (Donaldson et al., 1992a; Donaldson et al., 1992b) . The resultant inhibition of coat formation interrupts the membrane traffic regulatory functions they normally carry out (Lippincott-Schwartz et al., 1991; Klausner et al., 1992) . In view of the known inhibitory effect of BFA on coat formation and the predominance of coated structures in the pericentriolar area, we re-examined the influence of BFA on Langerin recycling. LCs were Figure 6F ). In contrast, the pericentriolar labelling, involving vesicular and tubular structures and the central linear striated density of BGs, was not unlike that seen after internalisation of gold-labelled DCGM4 in untreated cells (compare Figure 6I and 6G), except that there was no evidence of coating of these structures.
Brefeldin A Induces Fusion of Birbeck Granules with other Components of the Endocytic Pathway
Through its effect on coat formation, BFA has also been shown to induce fusion and redistribution of the membranes of the early endocytic pathway and the trans Golgi network (TGN) resulting in a continuous tubular network (Wood et al., 1991; Lippincott-Schwartz et al., 1991) . Thus, we next examined the effect of BFA on the relationship between BGs and the endosomal system. Epidermal cells were incubated at 37°C for 30 min with BFA (5 µg/ml) and then for 60 min in the presence of both BFA and HRP (10 mg/ml). Control cells were incubated for 60 min with HRP alone, a period sufficiently long to saturate the tubular endosomes and BGs with HRP (our unpublished results). The presence of BFA led to the appearance of elongated HRP positive BGs, which were frequently connected with tubular and vesicular structures. While in some places, the labelled BGs seemed to lie at the extremities of the tubular structures ( Figure 7A , A'), in other areas they clearly constituted an integral part of a tubular network ( Figure 7C -E).
Thus, it would appear that BFA on the one hand reduces the recycling of internalised Langerin and, on the other, promotes interconnections between BGs and components of the endosomal system. In fact, such tubular networks were also occasionally observed in untreated cells ( Figure 8A ). The internalisation of a gold-labelled anti-CD1a mAb to these network structures indicates that they correspond to the recycling compartment. Interestingly, some of the CD1a positive tubular networks and neighbouring BGs were coated ( Figure 8B -E). These results suggest that intracellular BGs form an integral part of the recycling pathway in Fi LCs.
Langerhans Cell Maturation Abolishes Langerin Cycling, and Results in the Depletion of Internal Langerin and Birbeck Granules
As many of the properties of LCs depend on their state of maturation, we examined the influence of the maturation of LCs on their ability to internalise Langerin. Although flow cytometry ( Figure 9G ) indicated that maturation had little overall effect on the cell surface expression of Langerin, confocal microscopy revealed a change in its distribution (compare Figure 9B and C with Figure 9A ). After 48 hours of maturation, the internal Langerin pool was markedly reduced or absent. At this time point, confocal images taken with fixed acquisition parameters (Salamero et al., 1996) showed a significant decrease in the intensity of total cell anti-Langerin fluorescence ( Figure 9H ). Moreover, the anti-Langerin mAb rapidly lost its ability to spontaneously internalise in LCs undergoing maturation (compare Figure 9E and F to Figure 9D ). As Langerin continuously recycles in LCs, this loss of the capacity to internalise could explain the depletion of the internal Langerin pool in mature LCs. In mature cells, inhibition of endocytosis with cytochalasin D/latrunculin A no longer resulted in an accumulation of Langerin at the cell surface, nor did BFA partly block recycling of Langerin to the cell surface ( Figure 9G ). At the ultra-structural level, cytochalasin D or latrunculin A, 18 both of which induced a 60% increase in the number of BG-like structures in Fi LCs, no longer triggered the appearance of BG-like structures appended to the cell membrane, nor did BFA induce the formation of continuous endosomal networks (our unpublished results). As compared to their immature counterparts, mature LCs were characterised by a smaller number of short rod like BGs (our unpublished results), dispersed among autophagolysosomes in the pericentriolar area, as previously described (Stössel et al., 1990) .
DISCUSSION
Though their presence in LCs was first described forty years ago, the origin and function of BGs has remained elusive. Two opposing theories have been proposed as to their function. The first suggests that BGs could function as alternative endocytotic structures, specific to LCs (Tarnowski and Hashimoto, 1967; Hashimoto, 1971; Takahashi and Hashimoto, 1985; Ishii et al., 1985; Takigawa et al., 1985; Bartosik, 1992) . However, in our hands and under physiological conditions, BGs appended to the cell surface were an exceptional finding, as previously reported by Wolff (1972) and Stössel et al. (1990) .
Moreover, we found no evidence that BGs participate in the internalisation of Langerin, pinched off the cell membrane in the presence of these drugs. However, not only BG-like structures were seen under these conditions, but also a large number of coated pits, which were labelled by gold conjugated anti-Langerin mAb, consistent with the recognised effect of these drugs on classical receptor-mediated endocytosis (Durrbach et al., 1996; Lamaze et al., 1997; Salamero et al., 2001 ). In addition, many of the BG-like structures were clathrin coated, or had labelled coated pits at their cytoplasmic terminal end. These findings indicate firstly that Langerin endocytosis is mediated by a classical clathrin coated pathway, regardless of whether the plasma membrane is linear or folded, as in the characteristic zipped formation of BG-like structures and, secondly, that BGs are not endocytotic structures.
The second proposed theory regarding BG function is that they could represent secretory structures formed in the Golgi area and involved in transport of cargo molecules to 20 the cell membrane. The disappearance of BGs from the pericentriolar area and concomitant appearance of BG-like structures at the cell membrane after cytochalasin D or latrunculin A treatment could signify that BGs act as transport intermediates "driving" Langerin, and perhaps other molecules, from internal membranes to the cell surface. On arrival at the cell surface such BGs would fuse with the plasma membrane, in a similar fashion to synaptic vesicles originating from the early endosomal pathway (Desnos et al., 1995) . Unzipping would follow, allowing delivery of their molecular content to the cell surface.
However, immunoelectron microscopy revealed BGs in continuity with tubular structures and also occasionally as part of early endosomal tubular networks in the pericentriolar area, networks which became manifest after treatment with BFA. In addition, after internalisation at 19.5°C and temperature shift to 37°C, Langerin was found both in the recycling compartments and in pericentriolar BGs. Thus it is apparent that BGs may simply represent membrane domains of tubular recycling endosomes, the morphology of which has been modified by the formation of molecular bridges. In this context, the elongated tubular configuration of the recycling compartment (Hopkins et al., 1994) could enable two membrane leaflets to come into close apposition, facilitating the generation of BGs. In contrast, such membrane interaction might not occur in early sorting endosomes because of their vesicular shape.
The predominance of BGs in the ERC could also be explained if the molecules responsible for their formation transiently accumulate in this compartment during their traffic.
We have demonstrated this to be the case for Langerin both in the steady state and after internalisation of anti-Langerin antibody. Moreover, when Langerin was redistributed and concentrated at the plasma membrane, by inhibition of endocytosis, numerous BG-like structures appended to the cell surface became apparent and, in mature LCs, when the internal pool of Langerin is depleted, there is a concomitant reduction in the number of BGs. Given its exclusive expression in LCs and the primacy of this relationship, it appears likely that BGs 21 arise through the interaction of Langerin molecules with one another and/or other ligands. We propose the hypothesis that when a "minimal zipping concentration" of these molecules is reached in the ERC, close membrane apposition is induced and BGs arise in pre-existing tubular structures. Similarly, BG-like structures form in membrane folds when Langerin is redistributed and concentrated at the plasma membrane.
Indeed, evidence exists to support this interpretation. Firstly, BGs can form within ER membranes in murine fibroblasts transfected with human Langerin cDNA (Valladeau et al., 2000) . In this non physiological situation, the ER membranes are likely to contain high levels of newly synthesised Langerin even in the steady state. Secondly, in CD34 + -derived LCs, which are characteristically clumped, we were able to generate BG-like structures between the plasma membranes of neighbouring cells by treatment with cytochalasin D (our unpublished results). Finally, unzipping of BGs by EDTA induces the appearance of vesiculo-tubular structures (Andersson et al., 1988) , suggesting that divalent cations are important in the bridging of BG membranes, which is significant as Langerin is a transmembrane type II Ca 2+ -dependent lectin (Valladeau et al., 2000) . These findings substantiate our belief that BGs represent morphological modifications of pre-existing membranes, rather than specific transport intermediates.
Nonetheless, other endosomal membrane proteins could also be implicated in the genesis of BGs. Hanau et al. (1991) for example, were able to induce the formation of such structures from the dilated elements of the surface-connected canalicular system of EDTAtreated human platelets. These morphological changes were dependent on the appearance of integrin α IIb homopolymers, acting as bridges between adjacent membranes of the surfaceconnected canalicular system and leading to their "zipping" (Gachet et al., 1993) .
The results of BFA treatment provide further insight into this unusual membrane trafficking process. BFA partially inhibited the effects of cytochalasin D treatment, namely the redistribution of Langerin from intracellular pools, recycling of internalised anti-Langerin 22 antibodies from the ERC and disappearance of gold-labelled anti-Langerin mAbs from the pericentriolar membrane structures, including BGs. This effect would appear to be mediated through inhibition of Arf dependent coat formation, a recognised consequence of BFA treatment (Chardin and McCormick, 1999) . Thus, while coated structures labelled with internalised anti-Langerin or anti-CD1a mAbs were seen in the pericentriolar area in the absence of drug treatment, after addition of BFA the labelled, fused tubular endosomes and pericentriolar BGs were no longer coated. In contrast, the BG-like structures appended to the cell surface generated by cytochalasin D or latrunculin A treatment remained coated with clathrin even in the presence of BFA. Hence, these latter coats must differ in composition from those of the pericentriolar BGs and tubular recycling endosomes. It is most probable that they represent AP-2 clathrin coats, as AP-2 recruitment is Arf1 independent (D'Souza- Schorey et al., 1995) and therefore unaffected by BFA (Robinson and Kreis, 1992) . This difference in coat composition provides persuasive evidence that the composition of BG-like structures differs from that of the pericentriolar BGs.
While the presence of clathrin coats on endosomes and their ability to segregate proteins have been previously described (Louvard et al., 1983; Le Borgne et al., 1996; Stoorvogel et al., 1996; Mallard et al., 1998) , the transport pathways in which they are involved remain obscure. Clathrin coats have been implicated in the transport of cargo proteins from early endosomes to an unknown destination, perhaps the plasma membrane (Stoorvogel et al., 1996) and by a retrograde pathway from early endosomes to the TGN (Mallard et al., 1998) , the route taken being dependent upon the nature of the adaptor protein complexes. On reaching the TGN, these cargo proteins may either pursue a retrograde pathway to the ER (Johannes et al., 1997) or resume the secretory route to the cell surface. Thus, TGN46 and furin, for example, recycle continuously between the plasma membrane, sorting endosomes, the ERC and the TGN. The kinetics of their traffic are nonetheless such that in the steady state these proteins are highly concentrated in the TGN (Ghosh et al., 1998; Mallet and Maxfield, 1999) . Likewise, there exist cycling proteins which are dynamically retained within organelles related to the early endosomal compartments (Johnson et al., 1993; Marsh et al., 1995; Johnson et al., 1998; Mayor et al., 1998) , such as GPI-linked proteins and the transmembrane insulin-regulated aminopeptidase which are concentrated in the ERC of fibroblasts (Mayor et al., 1998; Johnson et al., 2001) .
Therefore, the steady-state concentration of a protein within a compartment can result from a "dynamic" retention, achieved by slow recycling from the compartment to the cell surface coupled with rapid retrieval back to that compartment. Whether the steady state Although Langerin seems to be involved in the biogenesis of BGs, its functional role in LCs remains obscure. Interestingly, Langerin possesses a single carbohydrate recognition domain with a glutamate-proline-asparagine motif predicting mannose type specificity (Valladeau et al., 2000) , a potentially important property as LCs lack classical mannose receptors (Mommaas et al., 1999) . Ligands of Langerin have yet to be described, however it could serve as a receptor for the capture of specific microbial antigens by this unique population of antigen presenting cells. One can only speculate as to which antigen presenting molecules Langerin might deliver bound antigen, however, on the basis of our results, CD1a is a potential target presenting molecule. We have demonstrated that endocytosed Langerin and CD1a molecules share a common intracellular fate in LCs, travelling through identical intracellular compartments, including pericentriolar BGs. Moreover, endocytosis and 24 recycling of both molecules is arrested by LC maturation (Salamero et al., 2001) . Since BGs form where Langerin accumulates in the ERC and are depleted when LCs are activated, they could in this context, serve as a loading compartment and/or a membrane reservoir for antigens prior to LC maturation. To analyse the localisation of BGs, cells were first incubated for 1 hour at 37° in the chosen conditions, then prepared for immunoelectron microscopy as described in the Materials and Methods. Counts represent summation of serial median profiles (Cytochalasin D: 15, Latrunculin A: 11).
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